WO2000071710A3 - Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol - Google Patents
Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol Download PDFInfo
- Publication number
- WO2000071710A3 WO2000071710A3 PCT/FR2000/001426 FR0001426W WO0071710A3 WO 2000071710 A3 WO2000071710 A3 WO 2000071710A3 FR 0001426 W FR0001426 W FR 0001426W WO 0071710 A3 WO0071710 A3 WO 0071710A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acids
- genes involved
- diseases related
- expression products
- concerns
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000620087A JP2003518918A (ja) | 1999-05-25 | 2000-05-25 | コレステロール代謝疾患に関与する遺伝子の発現産物 |
AU49318/00A AU4931800A (en) | 1999-05-25 | 2000-05-25 | Expression products of genes involved in diseases related to cholesterol metabolism |
EP00931354A EP1183350A2 (fr) | 1999-05-25 | 2000-05-25 | Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol |
IL14583500A IL145835A0 (en) | 1999-05-25 | 2000-05-25 | Expression products of genes involved in diseases related to cholesterol metabolism |
MXPA01011882A MXPA01011882A (es) | 1999-05-25 | 2000-05-25 | Productos de expresion de genes implicados en enfermedades relacionadas con el metabolismo del colesterol. |
KR1020017015017A KR20020033627A (ko) | 1999-05-25 | 2000-05-25 | 콜레스테롤 대사 관련 질환에 관여된 유전자의 발현산물 |
CA002371500A CA2371500A1 (fr) | 1999-05-25 | 2000-05-25 | Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol |
BR0010916-9A BR0010916A (pt) | 1999-05-25 | 2000-05-25 | ácido nucleico, sonda ou iniciador de nucleotìdeo, processos e kits para amplificação de um ácido nucleico, para detecção de presença de um ácido nucléico e de um polipeptìdeo, para seleção de uma molécula ou de uma substância candidata que interage com um polipeptìdeo, vetor recombinante, célula hospedeira recombinante, polipeptìdeo, e, anticorpo |
HU0203164A HUP0203164A2 (hu) | 1999-05-25 | 2000-05-25 | Koleszterin-metabolizmussal kapcsolatos betegségekben érintett gének expressziós termékei |
NO20015729A NO20015729L (no) | 1999-05-25 | 2001-11-23 | Ekspresjonsprodukter av gener involvert i sykdommer relatert til kolesterolmetabolisme |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR99/06587 | 1999-05-25 | ||
FR9906587A FR2794131B1 (fr) | 1999-05-25 | 1999-05-25 | Produits d'expression de genes impliques dans des affections associees au metabolisme du cholesterol |
US13945099P | 1999-06-16 | 1999-06-16 | |
US60/139,450 | 1999-06-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000071710A2 WO2000071710A2 (fr) | 2000-11-30 |
WO2000071710A3 true WO2000071710A3 (fr) | 2001-05-17 |
Family
ID=26234967
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2000/001426 WO2000071710A2 (fr) | 1999-05-25 | 2000-05-25 | Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1183350A2 (fr) |
JP (1) | JP2003518918A (fr) |
KR (1) | KR20020033627A (fr) |
AU (1) | AU4931800A (fr) |
BR (1) | BR0010916A (fr) |
CA (1) | CA2371500A1 (fr) |
HU (1) | HUP0203164A2 (fr) |
IL (1) | IL145835A0 (fr) |
MX (1) | MXPA01011882A (fr) |
NO (1) | NO20015729L (fr) |
WO (1) | WO2000071710A2 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2367955C (fr) | 1999-03-15 | 2009-05-19 | University Of British Columbia | Methodes et reactifs permettant de moduler les taux de cholesterol |
AU2001279024B2 (en) * | 2000-08-01 | 2007-05-17 | Amgen Inc. | C3b/C4b complement receptor-like molecules and uses thereof |
AT413701B (de) * | 2001-11-06 | 2006-05-15 | Bmt Medizinische Forschung Und | Strukturelle und funktionelle charakterisierung von cdw92 |
WO2008081942A1 (fr) | 2007-01-05 | 2008-07-10 | The University Of Tokyo | Diagnostic et traitement de cancers utilisant un anticorps anti-prg-3 |
CA2705509A1 (fr) | 2007-11-14 | 2009-05-22 | Forerunner Pharma Research Co., Ltd. | Diagnostic et traitement du cancer a l'aide d'un anticorps anti-gpr49 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020165A2 (fr) * | 1996-11-06 | 1998-05-14 | Whitehead Institute For Biomedical Research | Marqueurs bialleliques |
-
2000
- 2000-05-25 EP EP00931354A patent/EP1183350A2/fr not_active Withdrawn
- 2000-05-25 WO PCT/FR2000/001426 patent/WO2000071710A2/fr not_active Application Discontinuation
- 2000-05-25 MX MXPA01011882A patent/MXPA01011882A/es unknown
- 2000-05-25 BR BR0010916-9A patent/BR0010916A/pt not_active IP Right Cessation
- 2000-05-25 CA CA002371500A patent/CA2371500A1/fr not_active Abandoned
- 2000-05-25 JP JP2000620087A patent/JP2003518918A/ja not_active Withdrawn
- 2000-05-25 HU HU0203164A patent/HUP0203164A2/hu unknown
- 2000-05-25 IL IL14583500A patent/IL145835A0/xx unknown
- 2000-05-25 AU AU49318/00A patent/AU4931800A/en not_active Abandoned
- 2000-05-25 KR KR1020017015017A patent/KR20020033627A/ko not_active Application Discontinuation
-
2001
- 2001-11-23 NO NO20015729A patent/NO20015729L/no not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998020165A2 (fr) * | 1996-11-06 | 1998-05-14 | Whitehead Institute For Biomedical Research | Marqueurs bialleliques |
Non-Patent Citations (8)
Title |
---|
"The WashU-Merck EST Project", Nombre d'accès: R55836; 28-MAi-1995 (Rel. 43, Created) Caractérisation de la séquence: yg89c04.r1 "Homo sapiens cDNA clone 40828 5' similar to contains MER2 repetitive element ";. * |
38TH ANNUAL MEETING OF THE COUNCIL ON ARTERIOSCLEROSIS, MIAMI, FLA., USA, NOV. 1984. * |
EMBASE numéro d'accès : AC AF088031; Créé le 09-SEPTEMBRE-1998 (Rel. 56) dernière mise à jour le 30-JUIN-1999 (Rel. 60,Version 2) Caractérisation de la séquence : Homo sapiens full length insert cDNA clone ZC22G07.Homo sapiens (human) * |
EMBASE, numéro d'accès (AC) AL047300; Créé le 13-MARS-1999 (Rel. 59) Dernière version le 20-FEVRIER-2000 (Rel. 62, Version 4) Caractérisation de la séquence : Homo sapiens mRNA; EST DKFZp586K1619_r1 (from clone DKFZp586K1619) * |
LISCUM L, MUNN NJ.: "Intracellular cholesterol transport.", BIOCHIM BIOPHYS ACTA., vol. 1438, no. 1, 19 April 1999 (1999-04-19), pages 19 - 37, XP000889761 * |
RUST, S. ET AL.: "Assignment of Tangier disease to chromosome 9q31 by a graphical linkage exclusion strategy.", NATURE GENETICS., vol. 20, no. 1, September 1998 (1998-09-01), pages 96 - 98, XP000884511 * |
SCHMITZ, G. ET AL.: "Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (Proapo A-I) with high density lipoproteins", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA., vol. 80, no. 19, October 1983 (1983-10-01), NATIONAL ACADEMY OF SCIENCE. WASHINGTON., US, pages 6081 - 6085, XP000877243, ISSN: 0027-8424 * |
ZANNIS V I ET AL.: "ISOLATION AND SEQUENCE OF TANGIER APOLIPOPROTEIN A-I GENE.", ARTERIOSCLEROSIS, vol. 4, no. 5, 1984, pages 562A, XP000884780 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000071710A2 (fr) | 2000-11-30 |
NO20015729L (no) | 2002-01-22 |
NO20015729D0 (no) | 2001-11-23 |
KR20020033627A (ko) | 2002-05-07 |
EP1183350A2 (fr) | 2002-03-06 |
JP2003518918A (ja) | 2003-06-17 |
BR0010916A (pt) | 2002-02-19 |
MXPA01011882A (es) | 2002-05-06 |
CA2371500A1 (fr) | 2000-11-30 |
IL145835A0 (en) | 2002-07-25 |
AU4931800A (en) | 2000-12-12 |
HUP0203164A2 (hu) | 2002-12-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1005540A4 (fr) | Proteines ikk-beta, acides nucleiques et procedes | |
WO2001072976A3 (fr) | 32142, 21481, 25964, 21686, nouvelles molecules deshydrogenases humaines et utilisations | |
WO2003023000A3 (fr) | Fragments d'adn lineaires destines a l'expression genetique | |
CY1107552T1 (el) | Ly6h γονιδιο | |
WO1997003192A3 (fr) | Gene du chromosome 1 et produits genetiques lies a la maladie d'alzheimer | |
EP1657256A3 (fr) | Compositions et méthodes pour traitement des tumeurs | |
CA2281895A1 (fr) | Ikb kinases | |
WO2005079367A3 (fr) | Synthase d'acide gras (fas) schizochytrium et produits et procedes connexes | |
CA2294566A1 (fr) | Proteines ikk-.alpha., acides nucleiques et procedes | |
WO2000061742A3 (fr) | Traitement d'une insuffisance cardiaque | |
WO2000019988A8 (fr) | NOUVELLES MOLECULES SPECIFIQUES DE Th2 ET LEURS UTILISATIONS | |
WO2000071710A3 (fr) | Produits d'expression de genes impliques dans des affections du metabolisme du cholesterol | |
WO2003062453A3 (fr) | Acides nucleiques et proteines associes a la polykystose renale | |
WO2003029422A3 (fr) | Gene du syndrome de noonan | |
WO2002004513A3 (fr) | Proteines 1 du type region critique 1 du syndrome de down | |
WO2001018216A3 (fr) | Nouvelle protease calpaine 26176 et utilisations | |
WO2007127347A3 (fr) | Fragment d'adn isolé du promoteur humain du gène sparc et son utilisation | |
WO2002081650A3 (fr) | Sequences nucleotidiques regulatrices d'alcool oxydase 1 pour l'expression de genes heterologues dans une levure | |
WO2003031594A3 (fr) | Sequences de nucleotides et d'acides amines associees a des maladies respiratoires et a l'obesite | |
WO2002064827A3 (fr) | Acides nucleiques du gene humain abca12, vecteurs contenant ces acides nucleiques, et utilisations associees | |
EP1430070A4 (fr) | Nouvelle proteine cark et molecules d'acides nucleiques et leurs utilisation | |
WO2002006485A3 (fr) | 47885, une nouvelle enzyme activant l'ubiquitine humaine et ses applications | |
EP1225182A3 (fr) | Transporteur phospholipidique humain | |
AU6235000A (en) | Method for enhancing rna or protein production using non-native 5' untranslated sequences in recombinant viral nucleic acids | |
ZA200202863B (en) | Novel cell cycle checkpoint genes and proteins encoded thereby. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: IN/PCT/2001/01040/DE Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2371500 Country of ref document: CA Ref document number: 2371500 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001/09129 Country of ref document: ZA Ref document number: 200109129 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 515452 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 49318/00 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2000 620087 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/011882 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020017015017 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000931354 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09979715 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000931354 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 1020017015017 Country of ref document: KR |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000931354 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1020017015017 Country of ref document: KR |